Schizophrenia/Psychosis

0.0(0)
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/108

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

109 Terms

1
New cards

Common symptoms

hallucinations, delusions, disorganized thinking/behaviour

2
New cards

Hallucinations

Sensing something not present

3
New cards

Delusions

Belief about something real that is not true

4
New cards

Disorganized thinking/behaviour

Inability to focus attention and communicate organized thoughts

5
New cards

Onset of symptoms

Young adulthood

6
New cards

Neurotransmitters involved

Dopamine, serotonin, glutamine

7
New cards

Medications causing psychosis

Anticholinergics, dextromethorphan, dopamine/dopamine agonists, interferons, stimulants, systemic steroids

8
New cards

Illicit substances causing psychosis

Cannabis, cocaine, LSD, methamphetamine, PCP, synthetic cathinones (bath salts, MDPV)

9
New cards

Negative symptoms

Loss of interest, lack of emotion, inability to carry out/plan activites, poor hygeine, social withdrawal, loss of motivation, lack of speech

10
New cards

Avolition

Lack of motivation

11
New cards

Alogia

Lack of speech

12
New cards

Positive signs and symptoms

Hallucinations (auditory or visual or somatic), delusions, disorganized thinking/behavior, difficulty paying attention

13
New cards

What symptoms (positive vs negative) do drugs typically treat

positiveS

14
New cards

Typical first-line treatment (general)

SGA

15
New cards

EPS symptoms

dystonias, dyskinesias, tardive dyskinesias, akathisia, parkinsonism

16
New cards

Dystonias

prolonged contraction of muscles; painful muscle spasms; higher risk in young males. Can be life threatening (airway)

17
New cards

Dystonia prophylaxis/treatment

Centrally acting anticholinergics; benztropine, diphenhydramine

18
New cards

Akathisia

restlessness with anxiety; inability to sit still

19
New cards

Akathisia treatment

BZDs or propranolol

20
New cards

Parkinsonism

Similar to parkinsons disease; tremors, abnormal gait and bradykinesia

21
New cards

Parkinsonism treatment

Anticholinergics (propranolol if tremor is main symptom)

22
New cards

Tardive dyskinesias

abnormal facial movements; primarily tongue or mouth; higher riks elderly females

23
New cards

Irreverisble EPS symptoms

TD

24
New cards

Tardive dyskinesia treatment

stop drug; replace with SGA with low EPS risk (quietiapine, clozapine)

25
New cards

Dyskinesias

Abnromal movments, more common with dopamine replacement for parkinson disease

26
New cards

Olanzapine + BZD = ?

excessive sedation and breathing difficulty; avoid

27
New cards

Black Box Warnings; General

Not indicated for agitation control in elderly with dementia related psychosis; increased risk of mortality (CV).

Increased risk for stroke

Warning of falls

28
New cards

FGA; MOA

Blocking D2 receptors, minimal 5HT2a blockage.

29
New cards

-azine ending

Phenothiazines

30
New cards

High potency FGAs

Haloperidol, fluphenazine, thiotixen, trifluoperazine

31
New cards

Mid potency FGAs

loxapine, pherphenazine

32
New cards

Low potency FGAs

Chlopromazine, thioridazine

33
New cards

Loxapine (inhalation brand)

Adasuve

34
New cards

Haloperidol class

Butryophenone

35
New cards

Boxed warning; thioridazine

QT prolongation

36
New cards

Boxed warning; adasuve

Bronchospasm (REMS)

37
New cards

FGA warnings (general)

CV, anticholinergic, CNS depression, EPS, hyperprolactinemia, NMS, Blood dyscrasias

38
New cards

FGA- CV

Qt prolongation, orthostatic/falls, tachycardia

39
New cards

FGA- highest QT prolongations

Thioridazine, haloperidol, chlorpromazine

40
New cards

FGA- anticholinergic

constipation, xerostomia, blurred vision, urinary retention

41
New cards

FGA- hyperprolactinemeia

infertility, oligomenorrhea/amenorrhea, glactorrhea, erectile dysfunction, decreased libido

42
New cards

FGA- NMS (neuroleptic malignant syndrome)

mental status changes, fever, muscle rigitidy, autonomic instability

43
New cards

FGA- blood dyscrasias

leukonpenia, nuetropenia, agranulocytosis, ocular effects

44
New cards

FGA sides effects

Sedation dizziness, anticholinergic effects, increased prolactin

EPS

45
New cards

Adasuve side effects

dysgeusia

46
New cards

Lower potency drug effect on EPS and sedation

lower EPS; higher sedation

47
New cards

Higher potency drug effect on EPS and sedation

higher EPS; lower sedation

48
New cards

SGA MOA; general

block D2 and 5HT2A

49
New cards

D2 and 5HT1a partial agonist

aripiprazole, cariprazine

50
New cards

D2 and 5HT1a partial agonist; 5HT2a antagonist

brexpiprazole

51
New cards

Aripiprazole (abilify) side effects

akathisia, activing or sedating, headache, anxiety, constipation; lower risk weight gain, some QT prolongation; EPS in children

52
New cards

Aripiprazole- Aristada initio

one time IM LD dose with oral aripiprazole

53
New cards

Ability MyCite

aripiprazole tablets wtih ingestible sensor

54
New cards

Clozapine (generic)

Clozaril, Versaclox susp (brand)

55
New cards

Clozapine; use when?

Failure to 2 AP treatments or significant ADRs

56
New cards

Clozapine BBW

Neutropenia/agranulocytosis

Bradycardia, orthostatic HoTn, syncope and cardiac arrest (highest during titration period- titrate slowly)

Mycoarditis and cardiomyopathy

Siezures (start no higher than 12.5mg QD/BID)

57
New cards

Clozapine REMS

neutropneia/agranulocytosis

Start; ANC must be >1500

ANC weekly x 6 mo; then q2week x 6mo; then monthly

D/C if ANC <1000

58
New cards

Clozapine; side effects

agranulocytosis, seizures, contsipation, somnolence, metabolic syndrome, sialorrhea, hypotension

59
New cards

Metabolic syndrome

Increased weight, BG, lipids

60
New cards

Sialorrhea

hypersalivation

61
New cards

Clozapine and smoking

Smoking reduces drug levels

62
New cards

Lurasidone (generic)

Latuda (brand)

63
New cards

Lurasidone CI

Use wtih a strong CYP450 3A4 inducer/inhibitor

64
New cards

Lurasidone side effects

somnolence, EPS (dystonia), N

Decreased risk of Metabolic syndrome vs other SGAs

65
New cards

Zyprexa Relprevv BBW

sedation (coma) and delirium (agitation, anziety, confusion, disorientation); monitor for 3 hours post injection; REMS

66
New cards

Olanzapine side effects

Smonolence, metabolic syndrome, orthostasis

67
New cards

Olanzapine and smoking

Smoking reduces drug levels

68
New cards

Olanzapine and lybalvi (samidrophan) use

Mitigate weight gain; opioid reeptor antagonist; cannot use in those using opioids/opioid withdrawal

69
New cards

Paliperidone (generic)

Invega (brand)

70
New cards

Paliperidone, risperidone side effects

incrased prolactin, eps (esp at higher doses), metabolic syndrome, somnolence, tachycardia, qt prolongation

71
New cards

Quetiapine (generic)

seroquel (brand)

72
New cards

Quetiapine side effects

Somnolence, metabolic syndome, orthostasis, possible occular effects/cataracts

Low EPS risk

73
New cards

Agent commonly used for psychosis in parkinsons disease

quetiapine/seroquel

74
New cards

Ziprasidone (generic)

Geodon (brand)

75
New cards

Ziprasidone CI

QT prolongation; do NOT use wtih QT risk

76
New cards

Ziprasidone; side effects

QT prolongation

somnolence, EPS, dizziness, nausea

77
New cards

Asenapine (generic)

Spahris, secuado (brand)

78
New cards

Asenapine CI

severe hepatic impairment

79
New cards

Asenapine side effects

somnolence, tongue numbness, EPS (slight), QT prolongation

80
New cards

Cariprazine (generic)

Vraylar (brand)

81
New cards

Cariprazine side effects

eps, dystonias, headache, insomnia

82
New cards

Brexpiprazole (generic)

Rexulti (brand)

83
New cards

Brexpiprazole side effects

weight gain, dyspepsia, diarrhea, akathisia

84
New cards

Iloperidone (generic)

Fanapt (brand)

85
New cards

iloperidone side effects

dizziness, somnolence, orthostasis, tachycardia, QT prolongation

86
New cards

lumateperone (generic)

caplyta (brand)

87
New cards

Lumateperone side effects

somnolence, eps

88
New cards

Questions to ask for treatment (5)

Did it work/well tolerated (with adequate adherence)

CV risk/QT prolongation

Hx of movement disorder (parkinsons)

Overweight/metabolic risk

Nonadherence/unhoused patients

89
New cards

Stat; acute psychosis / NPO

haloperidone, diphenhydramine, lorazepam

ziprasidone or olanzapine IM

90
New cards

Pimavanserin (generic)

nuplazid (brand)

91
New cards

pimavanserin moa

inverse agnoist and antagonist at 5HT2a receptors; less extent at 5HT2c receptors. No effect on dopamine

92
New cards

Where do you use pimavanserin?

Parkinsons disease psychosis

93
New cards

Pimavanserin warnings

not approved for dementia related psychosis

Qt prolonging.

94
New cards

Pimavanserin side effects

QT prolongation, peripheral edema, confusion

95
New cards

Risperidone caution with WHAT cyp?

cyp 2d6 inhibitors (paroxetine, fluoxetine)

96
New cards

valbenazine and deutrabenazine moa

reversibly inhibitor VMAT2 (receptor regualting monoamine uptake from cytopalsm to synaptic vesicle)

97
New cards

Valbenazine (generic)

ingrezza (brand)

98
New cards

Valbenazine warnings

qt prolongation, smonolence. Pgp inhibitor; increase digoxin concentrations. avoid with MAOi

99
New cards

Deutrabenazine (generic)

austedo (brand)

100
New cards

Deutrabenazine ci

hepatic impairement; co adminstration with tetravenazine or valbenazine; MAOi within 14 days